References
- Tombacz I , WeissmanD, PardiN. Vaccination with messenger RNA: a promising alternative to DNA vaccination. In: DNA Vaccines. Methods in Molecular Biology (Volume 2197).Sousa ( Ed.). Humana, NY, USA, 13–31 (2021).
- Maugeri M , NawazM, PapadimitriouAet al. Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells. Nat. Commun.10, 4333 (2019).
- Walsh EE , FrenckRWJr, FalseyARet al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N. Engl. J. Med.383(25), 2439–2450 (2020).
- World Health Organization . WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/
- Hoffmann M , Kleine-WeberH, SchroederSet al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell181(2), 271–280 (2020).
- Huang C , WangY, LiXet al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet395(10223), 497–506 (2020).
- Riley RS , JuneCH, LangerR, MitchellMJ. Delivery technologies for cancer immunotherapy. Nat. Rev. Drug. Discov.18(3), 175–196 (2019).
- Santos PM , ButterfieldLH. Dendritic cell-based cancer vaccines. J. Immunol.200(2), 443–449 (2018).
- Ni J , SongJ, WangBet al. Dendritic cell vaccine for the effective immunotherapy of breast cancer. Biomed. Pharmacother.126, 110046 (2020).
- Cedolini C , BertozziS, LonderoAPet al. Type of breast cancer diagnosis, screening, and survival. Clin. Breast Cancer14(4), 235–240 (2014).
- Van Zelst JCM , VreemannS, WittHJet al. Multireader study on the diagnostic accuracy of ultrafast breast magnetic resonance imaging for breast cancer screening. Invest. Radiol.53(10), 579–586 (2018).
- Lelyveld VS , BrustadE, ArnoldFH, JasanoffA. Metal-substituted protein MRI contrast agents engineered for enhanced relaxivity and ligand sensitivity. J. Am. Chem. Soc.133(4), 649–651 (2011).
- Lee M , HeoSH, SongIHet al. Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis. Mod. Pathol.32(1), 70–80 (2019).
- Zare H , RajabibazlM, RasooliIet al. Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells. Int. J. Biol. Marker.29(2), E169–E179 (2014).
- Robbiani DF , GaeblerC, MueckschFet al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature584(7821), 437–442 (2020).
- World Health Organization . WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All.World Health Organization, Geneva, Switzerland (2020).
- Vollmer J , KriegAM. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv. Drug. Deliv. Rev.61(3), 195–204 (2009).